Swiss National Bank Senseonics Holdings, Inc. Transaction History

Swiss National Bank

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$0.68 - $1.25 $59,092 - $108,625	-86,900 Reduced 8.14%	980,700 $696,000
Q4 2022 Feb 08, 2023	BUY	$0.96 - $1.34 $181,248 - $252,992	188,800 Added 21.48%	1,067,600 $1.1 Million
Q3 2022 Nov 09, 2022	BUY	$1.02 - $2.23 $39,168 - $85,632	38,400 Added 4.57%	878,800 $1.16 Million
Q2 2022 Aug 09, 2022	SELL	$0.94 - $1.94 $52,640 - $108,640	-56,000 Reduced 6.25%	840,400 $866,000
Q1 2022 May 09, 2022	BUY	$1.54 - $3.71 $97,944 - $235,956	63,600 Added 7.64%	896,400 $1.77 Million
Q4 2021 Feb 08, 2022	BUY	$2.58 - $3.91 $80,238 - $121,601	31,100 Added 3.88%	832,800 $2.22 Million
Q2 2021 Aug 06, 2021	BUY	$1.71 - $4.14 $1.37 Million - $3.32 Million	801,700 New	801,700 $3.08 Million
Q4 2019 Feb 06, 2020	SELL	$0.83 - $1.3 $191,730 - $300,300	-231,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$0.97 - $1.94 $48,500 - $97,000	50,000 Added 27.62%	231,000 $228,000
Q2 2019 Aug 02, 2019	BUY	$1.81 - $2.45 $45,974 - $62,230	25,400 Added 16.32%	181,000 $369,000
Q4 2018 Feb 13, 2019	BUY	$2.49 - $4.54 $387,444 - $706,424	155,600 New	155,600 $403,000

137

60M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $526M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.